Charles River Laboratories (CRL)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	1,608,660	1,444,320	1,504,780	1,448,360	1,439,030	1,415,350	1,393,090	1,333,090	1,274,100	1,379,040	1,267,910	1,423,210	1,201,130	1,140,270	1,234,720	1,208,280	1,021,320	972,407	1,010,060	866,182
Total current liabilities	US$ in thousands	1,055,080	993,816	1,007,620	981,392	1,091,580	1,014,190	1,048,140	993,839	1,033,180	983,751	929,610	803,376	839,751	787,014	727,936	690,896	710,181	681,646	635,598	529,759
Current ratio		1.52	1.45	1.49	1.48	1.32	1.40	1.33	1.34	1.23	1.40	1.36	1.77	1.43	1.45	1.70	1.75	1.44	1.43	1.59	1.64

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $1,608,660K ÷ $1,055,080K
= 1.52

The current ratio of Charles River Laboratories has exhibited fluctuations over the past few years, ranging from 1.23 to 1.77. The current ratio indicates the company's ability to cover its short-term liabilities with its current assets.

Analyzing the trend, we observe that the current ratio has generally been above 1, suggesting that the company has had sufficient current assets to cover its short-term obligations. The ratio peaked at 1.77 in the first quarter of 2021, indicating a strong liquidity position at that time.

However, the ratio has shown some variability since then, with fluctuations between 1.23 and 1.75. This indicates possible changes in the company's current asset and current liability composition impacting its liquidity position.

Overall, the company's current ratio suggests a generally healthy liquidity position, but investors and analysts may want to closely monitor future fluctuations to assess any potential impacts on the company's short-term financial health.